Q2 Earnings Forecast for SABS Issued By HC Wainwright
SAB Biotherapeutics, Inc. (NASDAQ:SABS – Free Report) – Analysts at HC Wainwright issued their Q2 2025 EPS estimates for SAB Biotherapeutics in a note issued to investors on Wednesday, May 14th. HC Wainwright analyst E. Bodnar anticipates that the company will earn ($0.58) per share for the quarter. HC Wainwright currently has a “Buy” rating […]
SAB Biotherapeutics, Inc. (NASDAQ:SABS – Free Report) – Analysts at HC Wainwright issued their Q2 2025 EPS estimates for SAB Biotherapeutics in a note issued to investors on Wednesday, May 14th. HC Wainwright analyst E. Bodnar anticipates that the company will earn ($0.58) per share for the quarter. HC Wainwright currently has a “Buy” rating […]
-2028-municipal-bond-etf-logo-1200x675.jpg?v=20230510111747&w=240&h=240&zc=2){kind=logo}